HU210-induced downregulation in cannabinoid CB1 receptor binding strongly correlates with body weight loss in the adult rat

Neurochemical Research

Volumn 34, Issue 7, 2009, Pages 1343-1353

  Dalton, Victoria S ^a,b   Wang, Hongqin ^a,b   Zavitsanou, Katerina ^a,b  

^a AUSTRALIAN NUCLEAR SCIENCE AND TECHNOLOGY ORGANISATION   (Australia)

^b SCHIZOPHRENIA RESEARCH INSTITUTE   (Australia)

Author keywords

Autoradiography; Cannabinoid CB1; HU 210; Tolerance

Indexed keywords

4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; CANNABINOID 1 RECEPTOR; DEXANABINOL;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; CAUDATE NUCLEUS; CONTROLLED STUDY; CORRELATION ANALYSIS; DOSE RESPONSE; DRUG EFFECT; DRUG MEGADOSE; DRUG RECEPTOR BINDING; DRUG TOLERANCE; HIPPOCAMPUS; HYPOTHALAMUS; MALE; NONHUMAN; PRIORITY JOURNAL; PUTAMEN; RAT; RECEPTOR DOWN REGULATION; SINGLE DRUG DOSE; SUBSTANTIA NIGRA; WEIGHT REDUCTION;

ANIMALS; AUTORADIOGRAPHY; BASAL GANGLIA; BRAIN; CEREBRAL CORTEX; CYCLOHEXANOLS; DOWN-REGULATION; MALE; RATS; RATS, WISTAR; RECEPTOR, CANNABINOID, CB1; TETRAHYDROCANNABINOL; WEIGHT LOSS;

ANIMALIA; RATTUS;

EID: 65949095029     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11064-009-9914-y     Document Type: Article

References (63)

1. A Ameri 1999 The effects of cannabinoids on the brain Prog Neurobiol 58 315 348 10.1016/S0301-0082(98)00087-2
2. CL Benn LA Farrell JH Cha 2004 Neurotransmitter receptor analysis in transgenic mouse models Methods Mol Biol 277 231 260
3. CS Breivogel SR Childers 1998 The functional neuroanatomy of brain cannabinoid receptors Neurobiol Dis 5 417 431 10.1006/nbdi.1998.0229
4. 9-tetrahydrocannabinol treatment produces a time-dependent loss of cannabinoid receptors and cannabinoid receptor-activated G proteins in rat brain J Neurochem 73 2447 2459 10.1046/j.1471-4159.1999. 0732447.x
5. L Caberlotto R Rimondini A Hansson S Eriksson M Heilig 2004 Corticotropin-releasing hormone (CRH) mRNA expression in rat central amygdala in cannabinoid tolerance and withdrawal: evidence for an allostatic shift? Neuropsychopharmacology 29 15 22 10.1038/sj.npp.1300296
6. C Cadoni A Pisanu M Solinas E Acquas G Di Chiara 2001 Behavioural sensitization after repeated exposure to delta 9-tetrahydrocannabinol and cross-sensitization with morphine Psychopharmacology (Berl) 158 259 266 10.1007/s002130100875
7. M Cohen N Solowij V Carr 2008 Cannabis, cannabinoids and schizophrenia: integration of the evidence Aust N Z J Psychiatry 42 357 368
8. B Costa 2007 On the pharmacological properties of delta9- tetrahydrocannabinol (THC) Chem Biodivers 4 1664 1677 10.1002/cbdv.200790146
9. J De Vry KR Jentzsch E Kuhl G Eckel 2004 Behavioral effects of cannabinoids show differential sensitivity to cannabinoid receptor blockade and tolerance development Behav Pharmacol 15 1 12 10.1097/00008877-200402000-00001
10. L Degenhardt WD Hall 2008 The adverse effects of cannabinoids: implications for use of medical marijuana CMAJ 178 1685 1686 10.1503/cmaj.080585
11. WL Dewey 1986 Cannabinoid pharmacology Pharmacol Rev 38 151 178 (Pubitemid 16001329)
12. M Ellgren SM Spano YL Hurd 2007 Adolescent cannabis exposure alters opiate intake and opioid limbic neuronal populations in adult rats Neuropsychopharmacology 32 607 615 10.1038/sj.npp.1301127
13. F Fan Q Tao M Abood BR Martin 1996 Cannabinoid receptor down-regulation without alteration of the inhibitory effect of CP 55, 940 on adenylyl cyclase in the cerebellum of CP 55, 940-tolerant mice Brain Res 706 13 20 10.1016/0006-8993(95)01113-7
14. F Ferrari A Ottani D Giuliani 1999 Influence of the cannabinoid agonist HU 210 on cocaine- and CQP 201-403-induced behavioural effects in rat Life Sci 65 823 831 10.1016/S0024-3205(99)00309-4
15. RW Foltin MW Fischman MF Byrne 1988 Effects of smoked marijuana on food intake and body weight of humans living in a residential laboratory Appetite 11 1 14 10.1016/S0195-6663(88)80017-5
16. D Giuliani F Ferrari A Ottani 2000 The cannabinoid agonist hu 210 modifies rat behavioural responses to novelty and stress Pharmacol Res 41 45 51 10.1006/phrs.1999.0560 (Pubitemid 30008936)
17. D Giuliani A Ottani F Ferrari 2000 Effects of the cannabinoid receptor agonist, HU 210, on ingestive behaviour and body weight of rats Eur J Pharmacol 391 275 279 10.1016/S0014-2999(00)00069-8
18. S González M Cebeira J Fernández-Ruiz 2005 Cannabinoid tolerance and dependence: a review of studies in laboratory animals Pharmacol Biochem Behav 81 300 318 10.1016/j.pbb.2005.01.028
19. WD Hall L Degenhardt 2008 Cannabis use and the risk of developing a psychotic disorder World Psychiatry 7 68 71
20. M Herkenham AB Lynn MR Johnson LS Melvin BR de Costa KC Rice 1991 Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study J Neurosci 11 563 583
21. S Higgs DJ Barber AJ Cooper P Terry 2005 Differential effects of two cannabinoid receptor agonists on progressive ratio responding for food and free-feeding in rats Behav Pharmacol 16 5-6 389 393 10.1097/00008877-200509000- 00011
22. AC Howlett TM Champion GH Wilken R Mechoulam 1990 Stereochemical effects of 11-OH-delta 8-tetrahydrocannabinol-dimethylheptyl to inhibit adenylate cyclase and bind to the cannabinoid receptor Neuropharmacology 29 161 165 10.1016/0028-3908(90)90056-W
23. EM Jansen DA Haycock SJ Ward VS Seybold 1992 Distribution of cannabinoid receptors in rat brain determined with aminoalkylindoles Brain Res 575 93 102 10.1016/0006-8993(92)90428-C
24. TUC Järbe NV DiPatrizio 2005 Delta9-THC induced hyperphagia and tolerance assessment: interactions between the CB1 receptor agonist delta9-THC and the CB1 receptor antagonist SR-141716 (rimonabant) in rats Behav Pharmacol 16 5-6 373 380 10.1097/00008877-200509000-00009
25. JE Koch 2001 Delta(9)-THC stimulates food intake in Lewis rats: effects on chow, high-fat and sweet high-fat diets Pharmacol Biochem Behav 68 3 539 543 10.1016/S0091-3057(01)00467-1
26. JE Lauckner JB Jensen H-Y Chen H-C Lu B Hille K Mackie 2008 GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current Proc Natl Acad Sci USA 105 2699 2704 10.1073/pnas.0711278105
27. RR Leker N Gai R Mechoulam H Ovadia 2003 Drug-induced hypothermia reduces ischemic damage: effects of the cannabinoid HU-210 Stroke 34 2000 2006 10.1161/01.STR.0000079817.68944.1E
28. AH Lichtman BR Martin 2005 Cannabinoid tolerance and dependence Handb Exp Pharmacol 168 691 717 10.1007/3-540-26573-2-24
29. PJ Little DR Compton R Mechoulam BR Martin 1989 Stereochemical effects of 11-OH-delta 8-THC-dimethylheptyl in mice and dogs Pharmacol Biochem Behav 32 661 666 10.1016/0091-3057(89)90014-2
30. JA López-Moreno G González-Cuevas G Moreno M Navarro 2008 The pharmacology of the endocannabinoid system: functional and structural interactions with other neurotransmitter systems and their repercussions in behavioral addiction Addict Biol 13 160 187 10.1111/j.1369-1600.2008.00105.x
31. P Mailleux J-J Vanderhaeghen 1992 Distribution of neuronal cannabinoid receptor in the adult rat brain: a comparative receptor binding radioautography and in situ hybridization histochemistry Neuroscience 48 655 668 10.1016/0306-4522(92)90409-U
32. JL Martín-Calderón RM Muñoz MA Villanúa I del Arco JL Moreno F Rodríguez de Fonseca M Navarro 1998 Characterization of the acute endocrine actions of (-)-11-hydroxy-delta8-tetrahydrocannabinol- dimethylheptyl (HU-210), a potent synthetic cannabinoid in rats Eur J Pharmacol 344 77 86 10.1016/S0014-2999(97)01560-4
33. I Matias L Cristino V Di Marzo 2008 Endocannabinoids: some like it fat (and sweet too) J Neuroendocrinol 20 suppl 1 100 109 10.1111/j.1365-2826.2008. 01678.x
34. I Matias V Di Marzo 2007 Endocannabinoids and the control of energy balance Trends Endocrinol Metab 18 1 27 37 10.1016/j.tem.2006.11.006
35. DL McKinney MP Cassidy LM Collier BR Martin JL Wiley DE Selley LJ Sim-Selley 2008 Dose-related differences in the regional pattern of cannabinoid receptor adaptation and in vivo tolerance development to delta9- tetrahydrocannabinol J Pharmacol Exp Ther 324 664 673 10.1124/jpet.107.130328
36. R Mechoulam JJ Feigenbaum N Lander M Segal TUC Järbe AJ Hiltunen P Consroe 1988 Enantiomeric cannabinoids: stereospecificity of psychotropic activity Experientia 44 762 764 10.1007/BF01959156
37. S Munro KL Thomas M Abu-Shaar 1993 Molecular characterization of a peripheral receptor for cannabinoids Nature 365 61 65 10.1038/365061a0
38. RM Murray PD Morrison C Henquet M Di Forti 2007 Cannabis, the mind and society: the hash realities Nat Rev Neurosci 8 885 895 10.1038/nrn2253
39. KA Newell C Deng X-F Huang 2006 Increased cannabinoid receptor density in the posterior cingulate cortex in schizophrenia Exp Brain Res 172 556 560 10.1007/s00221-006-0503-x
40. A Ottani D Giuliani 2001 Hu 210: a potent tool for investigations of the cannabinoid system CNS Drug Rev 7 131 145 (Pubitemid 32656298)
41. H Ovadia A Wohlman R Mechoulam J Weidenfeld 1995 Characterization of the hypothermic effect of the synthetic cannabinoid HU-210 in the rat. Relation to the adrenergic system and endogenous pyrogens Neuropharmacology 34 175 180 10.1016/0028-3908(94)00133-D
42. A Oviedo J Glowa M Herkenham 1993 Chronic cannabinoid administration alters cannabinoid receptor binding in rat brain: a quantitative autoradiographic study Brain Res 616 293 302 10.1016/0006-8993(93)90220-H (Pubitemid 23200058)
43. U Pagotto G Marsicano D Cota B Lutz R Pasquali 2006 The emerging role of the endocannabinoid system in endocrine regulation and energy balance Endocr Rev 27 1 73 100 10.1210/er.2005-0009
44. D Parolaro D Viganò T Rubino 2005 Endocannabinoids and drug dependence Curr Drug Target CNS Neurol Disord 4 643 655 10.2174/ 156800705774933014 (Pubitemid 41782626)
45. T Pattij J Wiskerke ANM Schoffelmeer 2008 Cannabinoid modulation of executive functions Eur J Pharmacol 585 458 463 10.1016/j.ejphar.2008.02.099
46. Paxinos G, Watson C (2007) The rat brain in stereotaxic coordinates. Sydney, Academic Press
47. F Rodríguez de Fonseca JL Martín-Calderón R Mechoulam M Navarro 1994 Repeated stimulation of D1 dopamine receptors enhances (-)-11-hydroxy-delta 8-tetrahydrocannabinol-dimethyl-heptyl-induced catalepsy in male rats NeuroReport 5 761 765 (Pubitemid 24133995)
48. J Romero F Berrendero L García-Gil SY Lin A Makriyannis JA Ramos JJ Fernández-Ruiz 1999 Cannabinoid receptor and WIN-55, 212-2-stimulated [35S]GTPgammaS binding and cannabinoid receptor mRNA levels in several brain structures of adult male rats chronically exposed to R-methanandamide Neurochem Int 34 473 482 10.1016/S0197-0186(99)00020-0
49. J Romero F Berrendero J Manzanares A Pérez J Corchero JA Fuentes JJ Fernández-Ruiz JA Ramos 1998 Time-course of the cannabinoid receptor down-regulation in the adult rat brain caused by repeated exposure to delta9-tetrahydrocannabinol Synapse 30 298 308 10.1002/(SICI)1098-2396(199811) 30:3<298::AID-SYN7>3.0.CO;2-6
50. J Romero E García-Palomero JG Castro L García-Gil JA Ramos JJ Fernández-Ruiz 1997 Effects of chronic exposure to delta9-tetrahydrocannabinol on cannabinoid receptor binding and mRNA levels in several rat brain regions Brain Res Mol Brain Res 46 100 108 10.1016/S0169-328X(96)00277-X
51. J Romero I Lastres-Becker R de Miguel F Berrendero JA Ramos J Fernandez-Ruiz 2002 The endogenous cannabinoid system and the basal ganglia biochemical, pharmacological, and therapeutic aspects Pharmacol Ther 95 137 152 10.1016/S0163-7258(02)00253-X
52. Roser P, Vollenweider FX, Kawohl W (2008) Potential antipsychotic properties of central cannabinoid (CB(1)) receptor antagonists. World J Biol Psychiatry, print copy in press (originally published online Feb. 7, 2008, at www.informaworld.com/smpp/title~content=t713721967 )
53. T Rubino G Patrini M Parenti P Massi D Parolaro 1997 Chronic treatment with a synthetic cannabinoid CP-55, 940 alters G-protein expression in the rat central nervous system Brain Res Mol Brain Res 44 191 197 10.1016/S0006-8993(96) 00941-9
54. T Rubino D Vigano P Massi D Parolaro 2000 Changes in the cannabinoid receptor binding, G protein coupling, and cyclic AMP cascade in the CNS of rats tolerant to and dependent on the synthetic cannabinoid compound CP55, 940 J Neurochem 75 2080 2086 10.1046/j.1471-4159.2000.0752080.x
55. JD Salamone PJ McLaughlin K Sink A Makriyannis LA Parker 2007 Cannabinoid CB1 receptor inverse agonists and neutral antagonists: effects on food intake, food-reinforced behavior and food aversions Physiol Behav 91 4 383 388 10.1016/j.physbeh.2007.04.013
56. DM Semple AM McIntosh SM Lawrie 2005 Cannabis as a risk factor for psychosis: systematic review J Psychopharmacol 19 187 194 10.1177/ 0269881105049040
57. LJ Sim-Selley 2003 Regulation of cannabinoid CB1 receptors in the central nervous system by chronic cannabinoids Crit Rev Neurobiol 15 91 119 10.1615/CritRevNeurobiol.v15.i2.10
58. LJ Sim-Selley BR Martin 2002 Effect of chronic administration of R-(+)-[2,3-Dihydro-5-methyl-3-[(morpholinyl)methyl]pyrrolo[1, 2, 3-de]-1, 4-b enzoxazinyl]-(1-naphthalenyl)methanone mesylate (WIN55, 212-2) or delta(9)-tetrahydrocannabinol on cannabinoid receptor adaptation in mice J Pharmacol Exp Ther 303 36 44 10.1124/jpet.102.035618
59. Taylor DA, Yap CY (1985) Effect of chronic delta(9)-tetrahydrocannabinol and delta(9)-tetrahydrocannabinol administration in the rat. In: Harvey DJ (ed) Marihuana. IRL Press, Oxford, pp 279-286
60. AJM Verberne DA Taylor MR Fennessy 1980 Withdrawal-like behaviour induced by inhibitors of biogenic amine reuptake in rats treated chronically with delta 9-tetrahydrocannabinol Psychopharmacology (Berl) 68 3 261 267 10.1007/BF00428113 (Pubitemid 10124221)
61. J Villares 2007 Chronic use of marijuana decreases cannabinoid receptor binding and mRNA expression in the human brain Neuroscience 145 323 334 10.1016/j.neuroscience.2006.11.012
62. MP Viveros F Rodríguez de Fonseca FJ Bermudez-Silva JM McPartland 2008 Critical role of the endocannabinoid system in the regulation of food intake and energy metabolism, with phylogenetic, developmental, and pathophysiological implications Endocr Metab Immune Disord Drug Targets 8 220 230 10.2174/187153008785700082
63. T Wang J-P Collet S Shapiro MA Ware 2008 Adverse effects of medical cannabinoids: a systematic review CMAJ 178 1669 1678 10.1503/cmaj.071178